Alterations in WNT Signaling in Leukemias.

Area of Science:

• Molecular Biology
• Oncology
• Hematology

Background:

• The WNT/β-catenin signaling pathway is crucial for hematopoietic cell differentiation and proliferation.
• Dysregulation of this pathway is increasingly recognized in the pathogenesis of hematopoietic malignancies.
• Understanding these disruptions is key to developing targeted therapies for leukemias.

Purpose of the Study:

• To systematically review and organize the known molecular alterations in the WNT/β-catenin signaling pathway in leukemias.
• To consolidate data on the various mechanisms contributing to WNT pathway dysregulation in hematopoietic cancers.

Main Methods:

• Comprehensive literature review of studies investigating WNT/β-catenin signaling in leukemia.
• Systematization of identified molecular impairments, including genetic, epigenetic, and protein-level changes.
• Analysis of the functional consequences of these alterations in hematopoietic cells.

Main Results:

• Identified several key WNT pathway dysregulations in leukemia: hypersensitivity to WNT ligands, epigenetic repression of antagonists (SFRP, DKK, etc.), WNT ligand overexpression, impaired β-catenin degradation, and altered TCF/Lef transcription factor activity.
• Detailed molecular mechanisms include FZD protein overexpression, promoter hypermethylation of WNT antagonists, altered Lef1 and plakoglobin levels, GSK3β mutations, and BCR-ABL kinase-mediated β-catenin phosphorylation.
• These molecular defects contribute to uncontrolled proliferation and survival of leukemic cells.

Conclusions:

• The WNT/β-catenin pathway is a critical target in leukemia pathogenesis due to frequent and diverse molecular impairments.
• Systematizing these alterations provides a foundation for understanding leukemia development and identifying therapeutic strategies.
• Further research into targeting these specific WNT pathway defects holds promise for novel leukemia treatments.